XML 109 R11.htm IDEA: XBRL DOCUMENT v3.2.0.727
Restructuring and Employee Severance
 12 Months Ended
Jun. 30, 2015
Restructuring Charges [Abstract]  
Restructuring and Employee Severance
Restructuring and Employee Severance
The following table summarizes restructuring and employee severance costs related to our restructuring activities:
(in millions)
2015 (3)
 
2014 (4)
 
2013 (5)
Employee-related costs (1)
$
34

 
$
13

 
$
59

Facility exit and other costs (2)
10

 
18

 
12

Total restructuring and employee severance
$
44

 
$
31

 
$
71


(1)
Employee-related costs primarily consist of termination benefits provided to employees who have been involuntarily terminated and duplicate payroll costs during transition periods.
(2)
Facility exit and other costs primarily consist of lease termination costs, accelerated depreciation, equipment relocation costs, project consulting fees and costs associated with restructuring our delivery of information technology infrastructure services.
(3)
The majority of the restructuring and employee severance incurred during fiscal 2015 were related to restructuring activities within our Medical segment.
(4)
Includes $10 million of primarily facility exit and other costs related to the restructuring within our Medical segment described further below.
(5)
Includes $30 million of employee-related costs and $10 million of facility exit and other costs related to the restructuring within our Medical segment described further below.
On January 30, 2013, we announced a restructuring plan within our Medical segment. Under this restructuring plan, among other things, we have reorganized our Medical segment, moved production of procedure kits from our facility in Waukegan, Illinois to other facilities, consolidated office space and sold property in Waukegan, Illinois, and exited our gamma sterilization business in El Paso, Texas.
We did not recognize significant costs associated with this restructuring plan during fiscal 2015. We recognized costs, on a pre-tax basis, associated with this restructuring plan of $18 million and $51 million in fiscal 2014 and 2013, respectively. Costs recognized in fiscal 2014 included the loss to write down the property in Waukegan, Illinois as discussed in Note 4. Costs recognized in fiscal 2013 included the loss to write down our gamma sterilization assets as discussed in Note 4.
During the fourth quarter of fiscal 2013, we recognized $11 million of employee-related costs related to a restructuring plan within our Nuclear Pharmacy Services division.
The following table summarizes activity related to liabilities associated with restructuring and employee severance:
(in millions)
Employee-
Related Costs
 
Facility Exit
and Other Costs
 
Total
Balance at June 30, 2012
$
16

 
$
2

 
$
18

Additions
63

 
2

 
65

Payments and other adjustments
(24
)
 
(2
)
 
(26
)
Balance at June 30, 2013
$
55

 
$
2

 
$
57

Additions
23

 
1

 
24

Payments and other adjustments
(54
)
 
(3
)
 
(57
)
Balance at June 30, 2014
$
24

 
$
—

 
$
24

Additions
34

 
1

 
35

Payments and other adjustments
(36
)
 
(1
)
 
(37
)
Balance at June 30, 2015
$
22

 
$
—

 
$
22